SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending downwards as the community discusses a significant drop following earnings, despite a double beat and strong backlog, with concerns focusing on a cut in forward guidance and potential data center delays. Community members are debating whether this is a buying opportunity or a sign of deeper issues with the company's business model and debt. Some speculate on a potential AI bubble, while others point to long-term contracts and strong demand as reasons for optimism.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending due to recent dilution news and a $3 billion Meta AI infrastructure deal, leading to mixed community sentiment. While some investors express concerns about short-term impacts and potential overvaluation, others emphasize the long-term growth potential and strong partnerships with major tech companies. The community is actively debating the significance of the dilution and its effect on future stock performance.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to significant price movement and high trading volume, sparking discussions around a potential short squeeze. Community members are actively debating entry and exit points, while some highlight the company's cash position and potential for further gains. The stock's volatility and recent news have drawn attention, with comparisons being made to other low-float runners.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as the community discusses its potential for acquisition amidst a bidding war for a competitor, Metsera. Community members speculate on which pharmaceutical company will acquire Viking, with some suggesting a non-pharma player could emerge. The excitement is fueled by positive clinical data and the increasing importance of obesity and NASH assets in the market.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors closely monitor discussions surrounding its Alzheimer's drug, Blarcamesine, with community debates focusing on potential approval outcomes and the significance of an oral explanation from the EMA. Concerns over market manipulation and short selling are prevalent, while some investors express confidence based on the drug's safety profile and potential benefits, leading to speculation about a possible short squeeze.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending due to speculation of a potential short squeeze, supported by bullish technical indicators. Community members are pointing to warrant distributions and reported insider buying as potential catalysts. Some traders are also excited about the company's new CEO and AI-driven turnaround strategy.

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

LFS is trending due to a recent surge, with community members actively discussing its potential as a low-float runner and comparing it to similar IPOs. The stock's volatility and after-hours movement have captured attention, although some traders caution about potential pump-and-dump dynamics. The company's recent contract award and financials are also circulating as potential catalysts.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to CEO Lisa Su's optimistic long-term financial outlook presented at the company's analyst day, including projections of significant revenue growth and a $1 trillion data center market by 2030. The community is buzzing about AMD's potential to capture a larger share of the AI data center market, comparing it to Nvidia's dominance.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer ($PFE) is trending as investors discuss its potential acquisition of Metsera amidst a bidding war with Novo Nordisk, with community chatter focusing on whether Pfizer is overpaying and the implications for its pipeline. Some are speculating on a potential bidding war for Viking Therapeutics should Pfizer lose out. The stock's high trading volume and upcoming dividend are also contributing to the buzz.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global ($VG) is trending as investors digest ongoing legal challenges from major energy companies like Shell and BP regarding LNG contract disputes, with community sentiment reflecting frustration and concern over potential financial impacts and management strategy. Despite the legal headwinds, some investors see the dip as a buying opportunity, highlighting the company's increasing LNG export capacity and potential for long-term growth in the energy sector, especially with new projects and facilities coming online.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
